Equity Fundraising

When we advise companies on fundraising, it’s about enabling them to achieve their full potential.

We understand that optimising terms is critical, but also finding the right long-term partner for the next phase of growth. So we work with entrepreneurs to help articulate their equity story, target the best investors and negotiate the right deal.

CG Results recognise that you’re leading a fast-growth business that needs to keep performing well and delivering to the growth plan — and on a practical note, we take a lot of the process work away from you to ensure you have the headspace and time to focus on the business.

Equity Fundraising Deals

Apr 2022
has received investment from
and EnBW New Ventures, with follow-on investment from ETF Partners
Jul 2021
has received investment from
Jan 2021
has invested in
Nov 2020
has received investment from
Sep 2020
has received investment from
Jan 2020
has received investment from
Nov 2019
has invested in
Oct 2019
has acquired
Sep 2019
has received investment from
Sep 2019
has received investment from

CG Results. Great people creating great outcomes, together.

Latest Insights

Reports
23rd November 2022

Pharma Licensing – an introduction

We are pleased to share our introduction to Pharma Licensing. This guide provides an overview of both in and out-licensing as well as insights on what to anticipate during the process. We hope that you find this guide useful and look forward to discussing the underlying themes with you. Do get in touch! Click to […]

Insights
17th October 2022

Pharma Licensing: the why the how and a few things to get right

Platform or asset licensing has increasingly been utilised across the bio-pharmaceutical industry to achieve Corporate objectives by sharing intellectual property (IP).  IP includes patents and know-how and third-party proprietary technologies, compounds and products, and can be used to build on existing therapeutic areas, expand into different geographies or to diversify portfolios.  A pharma licensing deal […]

Reports
17th October 2022

MedTech Services – Drivers of growth and consolidation

Welcome to our MedTech Services Report. This sets out our views on the tailwinds driving growth and increased outsourcing, an overview of the MedTech CDMO and CRO market as well as the key drivers of consolidation in the sector. We hope that you enjoy this report and look forward to discussing the data and underlying […]